Avita Therapeutics Inc (ASX: AVH) Share Price and News
() Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
Recent Stock Announcements
|Date||Heading||An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.||Time||Pages||File Size|
Avita Therapeutics Inc (ASX: AVH) is a medical technology company that specialises in regenerative medicine. Avita’s leading product, the RECELL System, was developed to address unmet medical needs in burns. The RECELL System is used to prepare ‘spray-on skin cells’ by using a small amount of the patient’s own skin. This is a revolutionary way to treat severe burns and significantly reduces the amount of donor skin required.
RECELL was granted US Food and Drug Administration (FDA) approval in September 2018 for the treatment of acute thermal burns in patients 18 years and older. Since then, Avita has been undertaking studies to assess the use of the RECELL System in other applications. This includes the treatment of pediatric scald injuries, soft tissue reconstruction and vitiligo.
The Avita share price exploded in 2019, going from $0.081 to finish the year a phenomenal 696% higher at $0.645. With this, Avita earned itself a spot in the S&P/ASX 200 Index (ASX: XJO), as well as a place on many investors’ ASX watchlists.
Avita Therapeutics Inc (ASX: AVH) Latest News
James Mickleboro | September 26, 2020 7:54am
Avita Therapeutics Inc (ASX:AVH) and Ramelius Resources Limited (ASX:RMS) shares were among the worst performers on the ASX 200 last week... More »
James Mickleboro | September 14, 2020 3:20pm
The Avita Therapeutics Inc (ASX:AVH) share price is charging higher on Monday. Here's why the Avita share price is on the rise... More »
Kate O'Brien | August 4, 2020 11:05am
If you invested $10k in each of these shares 3 years ago, you would be sitting on more than $1.3 million today. More »
Kate O'Brien | August 3, 2020 2:49pm
Investors in these two ASX medical shares have locked in recent gains sending prices down significantly. Are they worthy long-term buys? More »
Kate O'Brien | August 3, 2020 8:33am
The S&P/ASX 200 ended July 29.9 points down. Here we take a look at the worst performing ASX 200 shares for the month. More »
James Mickleboro | August 2, 2020 10:45am
AVITA Therapeutics Inc (ASX:AVH) and AMP Limited (ASX:AMP) shares were among the worst performers on the ASX 200 in July... More »
Kate O'Brien | July 20, 2020 2:37pm
The S&P/ASX 200 Index (ASX: XJO) rose 1.9% last week to finish the week at 6033.6, having received a mid-week boost on hopes of... More »
Sebastian Bowen | July 20, 2020 8:46am
Here on our ASX 200 Foolish Weekly Wrap, we look at the things that moved the S&P/ASX 200 Index and the broader share market... More »
James Mickleboro | July 18, 2020 8:46am
AVITA Therapeutics Inc (ASX:AVH) and Mesoblast limited (ASX:MSB) shares were among the worst performers on the ASX 200 last week... More »
Kate O'Brien | July 15, 2020 10:57am
Here are two ASX medical device shares with promising developments on products that save and improve the lives of patients. More »
James Mickleboro | July 13, 2020 10:07am
The AVITA Therapeutics Inc (ASX:AVH) share price is surging higher on Monday after the release of a positive update on its U.S. operations... More »
Will Avita Medical pay a dividend in 2020?
Avita Therapeutics shares do not currently include a dividend payment. The company has made no announcements regarding paying a dividend in 2020.
Does Avita Medical offer a DRP?
No, Avita Therapeutics does not currently offer a dividend reinvestment plan (DRP).